ArticleAllergy2022

Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.

Joaquim Mullol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.